Nuclear Medicine Methods for Assessment of Chronic Chagas Heart Disease
AUTOR(ES)
Simões, Marcus Vinicius; Tanaka, Denise Mayumi; Marin-Neto, José Antonio
FONTE
Int. J. Cardiovasc. Sci.
DATA DE PUBLICAÇÃO
2020-12
RESUMO
Abstract Several different imaging methods can be used to evaluate patients with Chagas heart disease (CHD) for diagnostic and prognostic purposes, including plain chest radiography; echocardiography; myocardial perfusion scintigraphy, for detection of ischemia and fibrosis; radionuclide gated-angiography, for evaluation of biventricular function; 123I-MIBG labeling of sympathetic myocardial innervation; MRI, for detection and quantitation of myocardial fibrosis; and coronary angiography. This study aims to review the contributions of these nuclear medicine methods to understanding of the pathophysiology of chronic Chagas cardiomyopathy (CCC). Careful analysis and integration of findings provided by these imaging methods in patients with CCC at different stages has contributed significantly to improving understanding of several peculiarities of the disease. Clinical and experimental studies in animal models show that perfusion abnormalities detected in association with dysfunctional but viable myocardium are a common finding in CCC patients and correspond to areas of cardiac sympathetic denervation, as assessed by 123I-MIBG imaging. Furthermore, recent reports have demonstrated a close relationship between coronary microvascular disturbances and myocardial inflammation. Thus, ongoing research, mainly focused on refinements of 18F-FDF -PET techniques and further exploration of nuclear methods, such as SPECT, have the potential to contribute to detection and monitoring of early subclinical myocardial damage thereby enabling evaluation of therapeutic strategies targeting inflammation and microvascular ischemia that could result in better prognostic stratification of patients with CHD.
Documentos Relacionados
- Nuclear medicine methods in the assessment of acupuncture effects: a short review
- Gas exchange during exercise in different evolutional stages of chronic Chagas' heart disease
- The potential influence of atherogenic dyslipidemia on the severity of chronic Chagas heart disease
- Apical aneurysm of Chagas's heart disease.
- The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease